H.B. Fuller (NYSE:FUL) Reaches New 12-Month Low – Here’s What Happened

H.B. Fuller (NYSE:FUL)’s stock price reached a new 52-week low on Wednesday . The company traded as low as $60.73 and last traded at $61.45, with a volume of 38676 shares changing hands. The stock had previously closed at $61.30.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Vertical Research cut shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. Citigroup dropped their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Finally, JPMorgan Chase & Co. decreased their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, H.B. Fuller currently has an average rating of “Hold” and a consensus price target of $75.60.

H.B. Fuller Price Performance

The company has a 50 day moving average price of $67.65 and a 200 day moving average price of $75.26. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16. The firm has a market cap of $3.35 billion, a PE ratio of 26.52, a PEG ratio of 1.21 and a beta of 1.42.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company’s revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.32 EPS. Sell-side analysts expect that H.B. Fuller will post 4.07 EPS for the current fiscal year.

H.B. Fuller Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th will be paid a $0.2225 dividend. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date of this dividend is Thursday, February 6th. H.B. Fuller’s dividend payout ratio is presently 38.53%.

Hedge Funds Weigh In On H.B. Fuller

Several institutional investors have recently made changes to their positions in the stock. S&CO Inc. raised its position in H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock valued at $21,209,000 after acquiring an additional 920 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC lifted its stake in shares of H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after purchasing an additional 324,056 shares during the last quarter. Wesbanco Bank Inc. boosted its holdings in H.B. Fuller by 41.2% in the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in H.B. Fuller by 17.2% during the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after buying an additional 81,558 shares during the last quarter. 95.93% of the stock is owned by institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.